Skip to main content
Clinical Trials/JPRN-UMIN000042467
JPRN-UMIN000042467
Not yet recruiting
未知

The effects of test food intake on immune function: Placebo-controlled, double-blind, randomized, pararellel-group comparison study-2 - The effects of test food intake on immune function-2

Miura Clinic, Medical Corporation Kanonkai0 sites60 target enrollmentJune 30, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Miura Clinic, Medical Corporation Kanonkai
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 30, 2021
End Date
April 30, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miura Clinic, Medical Corporation Kanonkai

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Subjects with a history of diabetes, liver disease, renal disease, digestive system disease, heart disease, respiratory disease, peripheral angiopathy, and other diseases that may affect the results of this study, or subjects with surgical history (2\) Subjects with abnormal liver function and renal function test values (3\) Subjects with diseases currently being treated (4\) Subjects with food and drug allergies (5\) Subjects taking warfarin (6\) Subjects with anemia symptoms (7\) Subjects on a diet (8\) Subjects with irregular lives (9\) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi\-drugs during the test period (10\) Subjects who are continuously taking medicines (including OTC and prescription medicines) (11\) Subjects who are excessively ingesting alcohol (12\) Subjects who cannot stop drinking from the day before the test to the day of the test (13\) Pregnant persons or subjects who are planning to become pregnant or breastfeed during the test period (14\) Subjects who are participating in or will participate in other clinical trials at the start of this study, and within 4 weeks after the end of the study. (15\) Other subjects judged by the investigator to be inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials